Last January, BioWorld Insight asked whether, after a long bumpy road, RNA therapeutics could prosper in 2013. With a few exceptions, the answer was a resounding yes. (See BioWorld Insight, Jan. 7, 2013.) Read More
Many readers have noticed our new look. BioWorld and Medical Device Daily recently became part of Thomson Reuters. We have redesigned our products to reflect our new business family. BioWorld and Medical Device Daily are allied now with Thomson Reuters Cortellis, the advanced source for timely and accurate life sciences information. As our products continue to evolve, we are eager to hear your feedback on this and future changes. Read More
